null

SMILES: Cc1cc(F)ccc1-c1cccc(c1)C(O)\C=C\[C@H]1CCC(=O)N1CCCc1ccc(cc1)C(O)=O

InChI Key: InChIKey=VHROTHARGKCIBF-AUNKXPJZSA-N

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 4 hits for monomerid = 202310   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Prostaglandin E2 receptor EP4 subtype (Homo sapiens (Human))	BDBM202310 (US9540357, example 11 | US9540357, example 12) Show SMILES Cc1cc(F)ccc1-c1cccc(c1)C(O)\C=C\[C@H]1CCC(=O)N1CCCc1ccc(cc1)C(O)=O |r| Show InChI InChI=1S/C30H30FNO4/c1-20-18-25(31)11-14-27(20)23-5-2-6-24(19-23)28(33)15-12-26-13-16-29(34)32(26)17-3-4-21-7-9-22(10-8-21)30(35)36/h2,5-12,14-15,18-19,26,28,33H,3-4,13,16-17H2,1H3,(H,35,36)/b15-12+/t26-,28?/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	53	-9.92	n/a	n/a	n/a	n/a	n/a	7.4	25
Allergan, Inc. US Patent					Assay Description A 384-well drug plate was prepared to contain 6 test compounds, PGE2 and cAMP in 16 serial dilutions in triplicate, using a Biomek station. HEK-EBNA ...				US Patent US9540357 (2017) BindingDB Entry DOI: 10.7270/Q24M92QQ
					More data for this Ligand-Target Pair
Prostaglandin E2 receptor EP4 subtype (Homo sapiens (Human))	BDBM202310 (US9540357, example 11 | US9540357, example 12) Show SMILES Cc1cc(F)ccc1-c1cccc(c1)C(O)\C=C\[C@H]1CCC(=O)N1CCCc1ccc(cc1)C(O)=O |r| Show InChI InChI=1S/C30H30FNO4/c1-20-18-25(31)11-14-27(20)23-5-2-6-24(19-23)28(33)15-12-26-13-16-29(34)32(26)17-3-4-21-7-9-22(10-8-21)30(35)36/h2,5-12,14-15,18-19,26,28,33H,3-4,13,16-17H2,1H3,(H,35,36)/b15-12+/t26-,28?/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	>1.34E+3	>-8.01	n/a	n/a	n/a	n/a	n/a	7.4	25
Allergan, Inc. US Patent					Assay Description A 384-well drug plate was prepared to contain 6 test compounds, PGE2 and cAMP in 16 serial dilutions in triplicate, using a Biomek station. HEK-EBNA ...				US Patent US9540357 (2017) BindingDB Entry DOI: 10.7270/Q24M92QQ
					More data for this Ligand-Target Pair
Prostaglandin E2 receptor EP2 subtype (Homo sapiens (Human))	BDBM202310 (US9540357, example 11 | US9540357, example 12) Show SMILES Cc1cc(F)ccc1-c1cccc(c1)C(O)\C=C\[C@H]1CCC(=O)N1CCCc1ccc(cc1)C(O)=O |r| Show InChI InChI=1S/C30H30FNO4/c1-20-18-25(31)11-14-27(20)23-5-2-6-24(19-23)28(33)15-12-26-13-16-29(34)32(26)17-3-4-21-7-9-22(10-8-21)30(35)36/h2,5-12,14-15,18-19,26,28,33H,3-4,13,16-17H2,1H3,(H,35,36)/b15-12+/t26-,28?/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	>1.00E+4	>-6.82	n/a	n/a	n/a	n/a	n/a	7.4	25
Allergan, Inc. US Patent					Assay Description A 384-well drug plate was prepared to contain 6 test compounds, PGE2 and cAMP in 16 serial dilutions in triplicate, using a Biomek station. HEK-EBNA ...				US Patent US9540357 (2017) BindingDB Entry DOI: 10.7270/Q24M92QQ
					More data for this Ligand-Target Pair
Prostaglandin E2 receptor EP2 subtype (Homo sapiens (Human))	BDBM202310 (US9540357, example 11 | US9540357, example 12) Show SMILES Cc1cc(F)ccc1-c1cccc(c1)C(O)\C=C\[C@H]1CCC(=O)N1CCCc1ccc(cc1)C(O)=O |r| Show InChI InChI=1S/C30H30FNO4/c1-20-18-25(31)11-14-27(20)23-5-2-6-24(19-23)28(33)15-12-26-13-16-29(34)32(26)17-3-4-21-7-9-22(10-8-21)30(35)36/h2,5-12,14-15,18-19,26,28,33H,3-4,13,16-17H2,1H3,(H,35,36)/b15-12+/t26-,28?/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	>1.00E+4	>-6.82	n/a	n/a	n/a	n/a	n/a	7.4	25
Allergan, Inc. US Patent					Assay Description A 384-well drug plate was prepared to contain 6 test compounds, PGE2 and cAMP in 16 serial dilutions in triplicate, using a Biomek station. HEK-EBNA ...				US Patent US9540357 (2017) BindingDB Entry DOI: 10.7270/Q24M92QQ
					More data for this Ligand-Target Pair